Cytotoxic agents comprising new taxanes

Details for Australian Patent Application No. 2005313444 (hide)

Owner Aventis Pharma S.A.

Inventors Baloglu, Erkan; Miller, Michael L.; Chari, Ravi V. J.; Commercon, Alain

Agent A J Park

Pub. Number AU-B-2005313444

PCT Pub. Number WO2006/061258

Priority 04292898.6 07.12.04 EP

Filing date 2 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 10 November 2011

International Classifications

C07D 493/06 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/061258 Priority application(s): WO2006/061258

10 November 2011 Application Accepted

  Published as AU-B-2005313444

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313445-Cytotoxic agents comprising new C-2 modified taxanes

2005313443-Method for printing a binary hologram on a manufactured product, and optical lens with a binary hologram printed thereon